Breaking will be offline for scheduled maintenance Saturday, May 8 3 AM EST to 12 PM EST. We apologize for the inconvenience.


Thank you for sharing!

Your article was successfully shared with the contacts you provided.

A new application of DNA testing, already used in a number of worker’ comp cases, has the potential to save insurers billions of dollars in defense costs, a scientist who pioneered the process contends.

Dr. Bruce S. Gillis, chief executive officer of the Cytokine Institute in Los Angeles, said the trademarked technology–called “msds1″ (otherwise known as Cytokine testing)–can ascertain if a person has had an injurious exposure to virtually any chemical or toxin, as well as whether they experience pain from an injury.

Want to continue reading?
Become a Free
PropertyCasualty360 Digital Reader.


  • All news coverage, best practices, and in-depth analysis.
  • Educational webcasts, resources from industry leaders, and informative newsletters.
  • Other award-winning websites including and

Already have an account?


Join PropertyCasualty360

Don’t miss crucial news and insights you need to make informed decisions for your P&C insurance business. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including, and
  • Exclusive discounts on PropertyCasualty360, National Underwriter, Claims and ALM events

Already have an account? Sign In Now
Join PropertyCasualty360

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.